InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Mollen John T, Director. Director active across 2 companies, notably ALEXION PHARMACEUTICALS, INC.. Cumulatively, 4 filings have been published. The latest transaction was disclosed on 21 July 2021 — Disposition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
015,336 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000071·
015,336 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000071:0·
01,962 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000042·
01,962 shares0
Common Stock, par value $.0001 per share
SEC:0000899866-21-000042:0·
4 of 4 declarations
About Mollen John T
John T. Mollen is a Board Member at Alexion Pharmaceuticals, Inc., a company committed to developing therapies for rare diseases. As a board member, he contributes to the governance and strategy of the company. His experience in the pharmaceutical sector is valuable for Alexion in its mission to improve patients' lives.
